Download the Free Prime PubMed App to your smartphone or tablet.

Available for iPhone or iPad:

Unbound PubMed app for iOS iPhone iPadAlso Available:
Unbound MEDLINE
Unbound PubMed app for Android

Available for Mac and Windows Desktops and laptops:

Unbound PubMed app for WindowsUnbound PubMed app for MAC OS Yosemite Macbook Air pro
(Arthritis and Rheumatism[TA])
19,170 results
  • Biologics in SAPHO syndrome: A systematic review. [Review]
  • SASemin Arthritis Rheum 2018 Apr 17
  • Daoussis D, Konstantopoulou G, … Liossis SN
  • CONCLUSIONS: In SAPHO patients not responding to conventional treatment, TNF blockers appear to be the first choice. In patients failing TNF blockers, IL-1 inhibitors and biologics targeting the IL-17/IL-23 axis could be used.
  • Medications received by patients with juvenile dermatomyositis. [Journal Article]
  • SASemin Arthritis Rheum 2018 Mar 28
  • Kishi T, Bayat N, … Childhood Myositis Heterogeneity Study Group
  • CONCLUSIONS: Oral prednisone has been the mainstay of therapy in JDM, and prednisone was reduced faster in patients diagnosed after 1997 when there was also an increase in other medications. Specific medications received by patients with JDM correlated with year and age at diagnosis, myositis autoantibodies, onset severity, and illness features.
New Search Next